Alvotech and jamp pharma announce receipt of marketing authorization for jamteki™ (avt04), the first biosimilar of stelara® (ustekinumab)

Pr jamte ki tm is the second biosimilar developed under th is partnership that receives market ing authorization in ca nada.

ALVO Ratings Summary

ALVO Quant Ranking